Clinical Trial Update: Investigator's Initiated Phase II Study for Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

An investigator-initiated Phase II trial in pancreatic cancer is in progress, with no current status disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Tiltan Pharma Ltd. | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN